SEC Filings HubLive
Live feed
Filing

Form 4

Form 4
0001193125-26-390624·BridgeBio Oncology Therapeutics, Inc.

Filing metadata

Accession number
0001193125-26-390624
Form type
Form 4
Filer
BridgeBio Oncology Therapeutics, Inc.
CIK
CIK 1869105
Filed
Sep 14, 2026
Reporting period
Sep 10, 2026
Description
Insider transaction

Documents

Filed by